The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEHP.L Share News (EHP)

  • There is currently no data for EHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Neptune Calculus Income & Growth VCT Hit By Epistem Share Decline

Tue, 19th Nov 2013 15:56

LONDON (Alliance News) - Neptune-Calculus Income & Growth VCT PLC Tuesday said its net asset value per share declined by 4.9% during the third quarter, as a result of a decline in the share price of AIM-quoted Epistem Holdings PLC, one of the companies in which it invests.

"[Epistem] although still valued at 300% of original cost, saw a decline it its share price following the termination of a supply and distribution agreement with Becton Dickinson for its product "Genedrive"," Neptune said in a statement.

Neptune said it is still positive on Epistem's long-term prospects. Epistem shares were Tuesday quoted at 323.00, down 2.2% and not much above their 52-week low of 310.00 pence. The shares have traded as high as 585.00 pence in the period.

Neptune said the remainder of the quoted portfolio increased by 30% on a like-for-like basis compared with the FTSE All Share which increased by 4.7%

Neptune's net asset value per share was 52.69 pence on September 30, compared to 55.43 pence on June 30.

Shares in Neptune were Tuesday quoted at 40.00 pence, up 14%.

By Samuel Agini; samagini@alliancenews.com; @samuelagini

Copyright © 2013 Alliance News Limited. All Rights Reserved.

More News
25 Jul 2016 07:51

Epistem Changes Name To Genedrive To Better Reflect Company Focus

Read more
12 Jul 2016 16:31

CORRECT: DIRECTOR DEALINGS: Epistem Directors Take Part In Placing

Read more
12 Jul 2016 12:08

DIRECTOR DEALINGS: Epistem Holdings Directors Take Part In Placing

Read more
23 Jun 2016 07:13

Epistem Urges Shareholders To Back Placing As Cash Begins To Dwindle (ALLISS)

Read more
7 Jun 2016 08:42

Epistem Secures Cornerstone Investor For Planned Fundraising (ALLISS)

Read more
3 May 2016 07:11

Epistem Says Genedrive Human Genotyping Trial Completed Successfully

Read more
18 Apr 2016 08:59

Epistem Starts Full Indian Commercial Launch For Genedrive

Read more
31 Mar 2016 09:33

WINNERS & LOSERS SUMMARY: AO World Surges On Strong Fourth Quarter

Read more
31 Mar 2016 08:42

Epistem Loss Widens As Focus Remains On Product Launch

Read more
21 Mar 2016 15:37

US DoD awards another £2m for Epistem biohazard project

(ShareCast News) - Epistem Holdings was gearing up for the next stage of its development programme with the US Department of Defense on Monday, having been awarded funding to proceed. The AIM-traded company received $2.4m (£1.7m) for the first phase of the $7.8m programme in August last year, to dev

Read more
21 Mar 2016 08:50

Epistem Gets USD2.9 Million Funding For Biohazard Identification Test

Read more
18 Feb 2016 08:00

Epistem Says First Test On Hepatitis C Test Completed Successfully

Read more
22 Jan 2016 09:59

River & Mercantile UK Micro Cap Beats Index, Says Epistem "Hidden Gem"

Read more
13 Jan 2016 09:11

Epistem Holdings Appoints David Budd As New Chief Executive

Read more
16 Dec 2015 14:29

DIRECTOR DEALINGS: Epistem Executives Buy 60,000 Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.